Abiopharma

Clinical trial NCT03833479 updates: 1. completion date: 2025-12-01 → 2028-07-31 2. primary completion date: 2025-12-01 → 2028-07-31

Clinical trial NCT07641881 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-05-29

Clinical trial NCT07431086 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-12-28 → 2026-12-18 3. primary completion date: 2026-11-23 → 2026-11-13 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT01742299: enrollment: 155 → 250 participants.

Clinical trial NCT07539090: start date: 2026-06-01 → 2026-06-05.

Clinical trial NCT07346495: completion date: 2027-01-01 → 2026-08-01.

Clinical trial NCT06637371 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-06-07 → 2027-04-10 3. primary completion date: 2027-06-07 → 2027-04-10 4. enrollment: 124 → 21 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07214844 updates: 1. start date: 2026-04-01 → 2026-04-16 2. completion date: 2027-05-01 → 2028-05-01 3. primary completion date: 2027-05-01 → 2028-05-01

Prosafe SE: Annual report 2025 in ESEF format

Beeline Uzbekistan and DataVolt Partner to Advance Central Asia’s Digital Infrastructure